The majority of identified lncRNAs regulate TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-mediated apoptosis by either promoting or inhibiting the expression of Bcl-2, contributing to heightened tumor growth, increased metastatic potential, and enhanced resistance to chemotherapy. This evidence concerns the gene BCL2 and neoplasm.